Stay updated on Tabelecleucel for EBV+ PTLD Clinical Trial
Sign up to get notified when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.

Latest updates to the Tabelecleucel for EBV+ PTLD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check29 days agoChange DetectedThe page has removed a study related to Tabelecleucel for EBV+ PTLD, which was previously recruiting participants, and replaced it with a completed study with a later date. Additionally, multiple contact details for various doctors have been deleted.SummaryDifference7%
- Check36 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.9%
- Check43 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check50 days agoChange DetectedNew entries have been added for January 2025, while several December 2024 entries have been removed, including one marked as 'Active, not recruiting'.SummaryDifference0.8%
- Check57 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
Stay in the know with updates to Tabelecleucel for EBV+ PTLD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.